A patient in New York has been infected with a strain of E. coli highly resistant to last-resort antibiotic treatments, according to an article on the Becker's Infection Control and Clinical Quality website.
This is the second U.S. patient with the untreatable superbug infection, following a Pennsylvania patient first made public last month.
The mcr-1 gene gives bacteria resistance to colistin, a last-line-of-defense antibiotic used to combat a number of resistant microorganisms.
Going into 2017, the White House has requested $1.1 billion be allocated to efforts to combat antibiotic resistance in the U.S.
Texas Law Limits Backup Power Mandates for Senior Care Facilities
Cyber Crossfire: Why Healthcare Is Becoming a Battleground in Global Conflicts
UPMC Presbyterian Receives $65 Million Gift for New Bed Tower
Premier Health Partners Falls Victim to Cyber Incident
Backup Power's Expanding Role in Emergency Preparedness for Healthcare